Klaus J. Weber

SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro.

Amir Abdollahi, Kenneth E. Lipson, Xiaohong Han et al. · PubMed · 2003 · 149 citations

Medicine, Oncology, Radiation Oncology +17

Combination of Vascular Endothelial Growth Factor Receptor/Platelet-Derived Growth Factor Receptor Inhibition Markedly Improves Radiation Tumor Therapy

Carmen Timke, Heike Zieher, Alexandra Roth et al. · Clinical Cancer Research · 2008 · 132 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Radiosensitizing potential of gemcitabine (2′,2′-difluoro-2′-deoxycytidine) within the cell cycle in vitro

D. Latz, Katharina Fleckenstein, Michael J. Eble et al. · International Journal of Radiation Oncology*Biology*Physics · 1998 · 102 citations

Medicine, Cell Biology, Pharmacology +11

Trimodal Glioblastoma Treatment Consisting of Concurrent Radiotherapy, Temozolomide, and the Novel TGF-β Receptor I Kinase Inhibitor LY2109761

Mengxian Zhang, Tobias W. Herion, Carmen Timke et al. · Neoplasia · 2011 · 92 citations · Full text

Medicine, Oncology, Pharmacology +17

Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells

Marc Bischof, Amir Abdollahi, Ping Gong et al. · International Journal of Radiation Oncology*Biology*Physics · 2004 · 61 citations

Medicine, Oncology, Pharmacology +16